Author: Puschel, Klaus; Ferreccio, Catterina; Peñaloza, Blanca; Abarca, Katia; Rojas, Maria-Paulina; Tellez, Alvaro; Moore, Philippa; Cea, Ana Maria; Wilson, Carlos; Cid, Vicente; Montero, Joaquin
Title: Clinical and serological profile of asymptomatic and non-severe symptomatic COVID-19 cases: Lessons from a longitudinal study in primary care in Latin America Cord-id: 2tqxztm3 Document date: 2021_1_13
ID: 2tqxztm3
Snippet: BACKGROUND: Chile has one of the highest incidences of COVID-19 infection in the world. Primary care can play a key role in early detection and containment of the disease. There is a lack of information on the clinical profile of patients with suspected COVID-19 in primary care, and controversy on the effectiveness of rapid serologic tests in the diagnosis and surveillance of the disease. AIM: To assess the effectiveness of rapid serologic testing in detection and surveillance of COVID-19 cases
Document: BACKGROUND: Chile has one of the highest incidences of COVID-19 infection in the world. Primary care can play a key role in early detection and containment of the disease. There is a lack of information on the clinical profile of patients with suspected COVID-19 in primary care, and controversy on the effectiveness of rapid serologic tests in the diagnosis and surveillance of the disease. AIM: To assess the effectiveness of rapid serologic testing in detection and surveillance of COVID-19 cases in primary care. DESIGN & SETTING: A longitudinal study was undertaken, which was based on a non-random sample of 522 participants, including 304 symptomatic patients and 218 high-risk asymptomatic individuals. They were receiving care at four primary health clinics in an underserved area in Santiago, Chile. METHOD: The participants were systematically assessed and tested for COVID-19 with reverse transcriptase-polymerase chain reaction (RT-PCR) and serology at baseline, and were followed clinically and serologically for 3 weeks. RESULTS: The prevalence rate of RT-PCR confirmed COVID-19 cases were 3.5 times higher in symptomatic patients (27.5%; 95% confidence interval [CI] = 22.1 to 32.8) compared with asymptomatic participants (7.9%; 95% CI = 4.3 to 11.6). Similarly, the immune response was significantly different between both groups. Sensitivity of serologic testing was 57.8% (95% CI = 44.8 to 70.1) during the third week of follow-up and specificity was 98.4% (95% CI = 95.5 to 99.7). CONCLUSION: Rapid serologic testing is ineffective for detecting asymptomatic or non-severe cases of COVID-19 at early stages of the disease, but can be of value for surveillance of immunity response in primary care. The clinical profile and immune response of patients with COVID-19 in primary care differs from those in hospital-based populations.
Search related documents:
Co phrase search for related documents- accuracy assessment and logistic regression: 1, 2, 3, 4
- accuracy assessment and low accuracy: 1, 2
- accuracy assessment and low middle: 1, 2, 3
- accuracy assessment and low sensitivity: 1, 2, 3, 4, 5, 6, 7
- accuracy assessment and lr likelihood: 1
- accuracy assessment and lr likelihood ratio: 1
- local committee and logistic regression: 1, 2, 3
- local community and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- local community and low accuracy: 1, 2
- local community and low intensity: 1
- local community and low middle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- local level and lockdown strategy: 1
- local level and logistic regression: 1, 2, 3, 4, 5, 6
- local level and low middle: 1, 2, 3, 4, 5, 6
- local level and low remain: 1
- lockdown strategy and logistic regression: 1, 2, 3
- lockdown strategy and low middle: 1, 2, 3
- lockdown strategy and low remain: 1
- logistic regression and low accuracy: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date